Chardan Capital reaffirmed their buy rating on shares of REGENXBIO (NASDAQ:RGNX – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. They currently have a $52.00 ...

Ben McPoland considers a pair of investments that are performing awfully in his ISA portfolio so far this year. What's gone ...

Sarepta Therapeutics (NASDAQ:SRPT – Free Report) had its target price lowered by Scotiabank from $105.00 to $80.00 in a ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

There is one simple mission: to generate stellar capital returns for its investors by taking long-term stakes in some of the ...

We recently published a list of Should You Buy the Dip and Follow Insiders into These 10 Stocks?. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against ...

The rhetorical—if not yet real—decoupling between America and China, which business is afraid to speak out against, however ...

While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant ...

Iovance Biotherapeutics (NASDAQ: IOVA) is a biotech company with an innovative approach to developing cancer medicines. Here's what investors need to know about this small-cap biotech company. Iovance ...

The current US Commerce Secretary - Howard Luttnick - has once again targeted Ireland, calling our country his 'favourite tax ...

Howard Lutnick, a former investment banker and a key ally of US President Donald Trump, has highlighted the prevalence of US ...

These top robo-advisors charge low fees but still ... Here is a list of our partners and here's how we make money. The investing information provided on this page is for educational purposes ...